Intercell raises R&D spending leading to a wider Q3 loss

The Austrian vaccine producer, Intercell AG, nearly doubled its loss for the 2010 third quarter, a result that reflected adverse exchange rate movements, a decline in revenue and an increase in spending on late-stage clinical research.